Two-dose shot approved for Canadian adults.
Another COVID-19 vaccine has been approved for use in Canada.
Health Canada has authorized the two-dose Novavax Nuvaxovid vaccine for people aged 18 and older.
Clinical trails suggest the shot is 90 percent effective in protecting from symptomatic COVID-19 cases, and 100 percent effective in preventing severe disease, according to a release from the agency.
The vaccine's safety and effectiveness for children has not yet been determined.
Health Canada is recommending the two doses be administered 21 days apart.

Oxford OPP Lay Charges After Warrant Execution
Camping Season is Open at Pittock
Application Window Open for Oxford County Grants Program
PJHL Preview - Schmalz Cup Final
Oxford Winds Celebrates 30 Years
Nomination Period Opens for Municipal Election
Theft in Thamesford is Under Investigation
Winning Lotto 6/49 Ticket Sold in Oxford
Thamesford Lions Club Celebrates 65 Years
Yellow Frost Advisory Issued for Oxford
News Poll: Schmalz Cup 2026
Realtors Care Food Drive Returns Next Week
PJHL Playoff Recap - April 29th
Charges Laid After Altercation in Woodstock
New Partnership Protects Land in Oxford
Bomb Threat Unfounded in Woodstock
Big Projects Announced for TVDSB
Tick Season Reminders from Southwestern Public Health
PJHL Playoff Recap - April 28th
Highway Construction Approaching in Burgessville
Comments
Add a comment